Biotechnology News

July 17, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., today announced the presentation of key findings supporting the benefits of high-throughput NMR spectroscopy analysis at the American Association for Clinical Chemistry Meeting.

July 17, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--Phyton Biotech has been granted a Certificate of suitability to European Pharmacopeia (CEP) for its paclitaxel active pharmaceutical ingredient (API) produced from plant cell formation.

July 17, 2012

LOS ANGELES--(BUSINESS WIRE)--Gold Standard Diagnostics (GSD) today announced the addition of fully-automated Chemiluminescence Immunoassay (CLIA) processing capability to the powerful ThunderBolt® Automation Platform.

July 17, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--GE Healthcare today announced the final results from a phase 3 study of the investigational PET amyloid imaging agent, [18F]flutemetamol in terminally ill patients who had agreed to undergo postmortem...

July 17, 2012

DENVER, Colo.--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) announces the 9th BioWest Conference, September 11, 2012, at the Marriott City Center, Denver.

July 17, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. appointments Dominic Spinella, Ph.D., as Vice President of Clinical Development & Medical Affairs to provide leadership for all clinical development.

July 17, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide today announced Prometheus Laboratories Inc. has awarded the company an Oncology program. Immediate plans are commencing for two metastatic melanoma studies.

July 17, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a supply...

July 17, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Founder, Joseph DeSimone, Named Director of Kenan Institute

July 17, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading global provider of cloud-based clinical development solutions, today announced that it will release its second quarter 2012 financial results on Tuesday, July 31.

July 17, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Louis Renzetti, Ph.D., as vice president of strategic laboratory operations.

July 17, 2012

WOLFENBUETTEL, Germany--(BUSINESS WIRE)--Luxembourg will be utilizing Genome Trax for its next generation sequencing variant analysis. GT prioritizes human genome variants, identifies novel mutations & filters out irrelevant variants.

July 17, 2012

LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics, the drug development company targeting with antibody-drug conjugate “warhead” therapies, announce the appointment of former Genmab VP Dr Patrick van Berkel as Senior VP, R&D.

July 17, 2012

ST. PAUL, Minn. & TOKYO--(BUSINESS WIRE)--St. Jude Medical launches industry's first quadripolar technology in Japan. The Unify Quadra CRT-D was designed to more effectively manage the common challenges of patients with heart failure.

July 17, 2012

CAMPBELL, Calif.--(BUSINESS WIRE)--AOptix and Unisys form strategic alliance to collaborate on biometric identity services, including iris and face recognition solutions for immigration and national identity programs.

July 17, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced that it has entered into a research collaboration with premier academic and research institutions to sequence the genomes of up to 1,000 patients with amyotrophic lateral...

July 17, 2012

HATFIELD, Pa.--(BUSINESS WIRE)--Genisphere has adapted its pioneering 3DNA Dendrimer Signal Amplification technology for lateral flow point-of-care assays, providing improved sensitivity and enabling a new array of POC tests.

July 17, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

July 17, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today introduced Nextera Exome and Custom Enrichment kits, the Company’s latest targeted resequencing solutions offering sample preparation and enrichment in a single, integrated workflow...

July 17, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Data on PV-10 for metastatic melanoma will be presented at the prestigious ESMO (European Society for Medical Oncology) 2012 Congress in Vienna, Austria on October 1, 2012.

July 17, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Photometrics' CoolSNAP™ MYO and the CoolSNAP™ KINO CCD cameras offer scientists the ability to visualize much finer details at much higher sensitivity.

July 17, 2012

MAINZ, Germany--(BUSINESS WIRE)--Around three million Germans permanently suffer from tinnitus, which can cause some considerable impairment in daily life. According to the most recent research findings, tinnitus results from maladaptive learning...

July 17, 2012

SCOTTSDALE, Ariz. & LOS ANGELES--(BUSINESS WIRE)--Makucell announces scientific findings for proprietary technology, Asymmtate. Study results show Asymmtate in Renewnt skin care products may help even out pigmentation irregularities and skin...

July 17, 2012

BANGKOK--(BUSINESS WIRE)--Vejthani Hospital recommends gender selection methods for a couple who desire to select gender of babies at Vejthani ART Center in Bangkok Thailand.

July 17, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics AB (Publ) (STO:PREC), Corporate Identity No. 556545-6596 Interim Report for the Period January – June 2012 The group’s net sales for the interim period was SEK 11.4 million (9.4) The...

July 17, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million...

July 17, 2012

READING, England--(BUSINESS WIRE)--TranScrip Partners, the cutting-edge contract research organisation, announced the addition of two new Senior Partners.

July 17, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2012. The final results for the three and twelve months ended May 31, 2012 will be made available to...

July 16, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC) announced today that it has completed a private placement originally commenced in May 2012 pursuant to which it raised an aggregate of $9.1 million through the issuance of...

July 16, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), announced today its LAVIV order information for the second quarter ended June 30, 2012. During the second quarter of 2012, Fibrocell received orders for 387 biopsies, an increase...

July 16, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) and Array BioPharma (Nasdaq: ARRY) announced today an agreement for the discovery of a novel KIT inhibitor targeting resistance mutations for the treatment of GIST. GIST is a...

July 16, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2012 financial results conference call for 8:30 a.m. ET on Thursday, August 2, 2012. The schedules for the press release...

July 16, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that its second quarter 2012 operating results will be reported after market close on Tues. July 31, 2012. The company will also hold a conference call on the...

July 16, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., announced today that QuantoseT, its new prediabetes blood test, will be featured at the 2012 AACC Clinical Lab Expo, being held July 17-19 in Los Angeles, CA. Two poster...

July 16, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test and measurement instruments and accredited provider of calibration, repair and other...

July 16, 2012

RICHMOND, Va.--(BUSINESS WIRE)--AIBioTech, LLC and Fairfax Identity Laboratories (FIL) announced today the purchase of Mitotyping Technologies, LLC, one of the oldest and most experienced companies in the Forensic DNA analysis market. Mitotyping...

July 16, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada® (emtricitabine and tenofovir disoproxil fumarate), in combination...

July 16, 2012

PARIS--(BUSINESS WIRE)--Exonhit announced that patient enrollment was completed ahead of plan in its studies in France and the United States for the assessment of the performance of AclarusDx®.

July 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences, a clinical-stage biopharm company developing programmable therapeutics called AccurinsTM, today announced that Andrew J. Hirsch has joined the company as its Chief Financial Officer.

July 16, 2012

PETALUMA, Calif.--(BUSINESS WIRE)--Tegal closes acquisition of CollabRx, Inc., a privately held technology company in the rapidly growing market of interpretive content and data analytics for genomics-based medicine.

July 16, 2012

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Preliminary results demonstrate that the novel delivery of dexamethasone via Mercator’s platform Micro-Infusion Catheter inhibits restenosis

July 16, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB: ORGS) (“Orgenesis” or “the Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

July 16, 2012

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) reported today that the Company has achieved a medical milestone with its “ARTDIVA” (Arterial Remodeling Transient DIsmantling Vascular Angioplasty) clinical trial: the successful...

July 16, 2012

LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced that the companies have entered into a definitive agreement under which GSK will acquire HGS for US$14.25 per share in cash. The...

July 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today announced its participation in two upcoming conferences. Dr....

July 16, 2012

JACKSONVILLE, Fla.--(BUSINESS WIRE)--USA Patent Allowed for NovaBone Putty. The medical device is used for orthopedic surgeries and procedures for dental and craniofacial defects.

July 16, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) announced today that Chief Executive Officer Michael D. West, Ph.D. will present at the 2012 Agora Financial Investment Symposium on Tuesday, July 24, 2012, 4:40 p.m. PDT, at the...

July 16, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin and St. Jude Children's Research Hospital form research collaboration to study treatment for rare neurological disorder.

July 16, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, July 26, 2012 at 9 a.m. ET to discuss the company’s second quarter 2012 financial and operational...